Close Menu

mergers & acquisitions

The merger with Genpoint, which NorDiag acquired three years ago, was done to reduce expenses to both firms.

LabCorp will purchase the Genetics segment in its entirety, including all testing services, technology, intellectual property rights, and its nine testing laboratories and offer employment to all of its 1,900 employees.

The firms will combine Biosystems International's monoclonal antibody proteomics process with MBC's microarray technology.

Upon completion of the acquisition, the combined company's focus will be strictly on Lumigene's business of developing diagnostics using its nucleic acid amplification platform.

The French firm gains access to Cyto Pulse's electroporation technologies and equipment.

Power3 will use Rozetta-Cell's stem cell technology with its own technology to develop screening and diagnostic tests.

Details about the "approach, which may or may not lead to an offer for the company," will be provided "in due course," Silence said. The news comes as an more and more drug makers are opting to acquire RNAi shops with technologies of interest rather than collaborating with them.

The acquisition adds drug discovery alliances to Evotec's portfolio of core assets, including one with Boehringer Ingelheim worth up to €237 million in potential milestone payments.

The company said that Ion Torrent's benchtop Personal Genome Machine, which is scheduled for commercial release later this year, is "highly complementary" to its capillary electrophoresis and SOLiD sequencing platforms and is "optimal for mid-scale sequencing projects, such as targeted and microbial sequencing."

Life Technologies gains access to Ion Torrent's sequencing platform, which is currently in the hands of early-access customers and will be launched later this year at an entry cost of less than $100,000. It noted that the total acquisition price could rise to $725 million if milestones are met.


Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.